Acidic Nanoparticles Restore Lysosomal Acidification and Rescue Metabolic Dysfunction in Pancreatic β-Cells under Lipotoxic Conditions
ACS Nano · 18.06.2024 · 18 (24) · 15452-15467
DOI: 10.1021/acsnano.3c09206 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 03.06.2024. Verfasst von Chih Hung Lo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore. Hauptthemen laut MEDLINE: Lysosomes, Nanoparticles, Insulin-Secreting Cells. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Momental Foundation, Nanyang Technological University.
Abstract (Originalsprache)
Type 2 diabetes (T2D), a prevalent metabolic disorder lacking effective treatments, is associated with lysosomal acidification dysfunction, as well as autophagic and mitochondrial impairments. Here, we report a series of biodegradable poly(butylene tetrafluorosuccinate-co-succinate) polyesters, comprising a 1,4-butanediol linker and varying ratios of tetrafluorosuccinic acid (TFSA) and succinic acid as components, to engineer lysosome-acidifying nanoparticles (NPs). The synthesized NPs are spherical with diameters of ≈100 nm and have low polydispersity and good stability. Notably, TFSA NPs, which are composed entirely of TFSA, exhibit the strongest degradation capability and superior acidifying properties. We further reveal significant downregulation of lysosomal vacuolar (H+)-ATPase subunits, which are responsible for maintaining lysosomal acidification, in human T2D pancreatic islets, INS-1 β-cells under chronic lipotoxic conditions, and pancreatic tissues of high-fat-diet (HFD) mice. Treatment with TFSA NPs restores lysosomal acidification, autophagic function, and mitochondrial activity, thereby improving the pancreatic function in INS-1 cells and HFD mice with lipid overload. Importantly, the administration of TFSA NPs to HFD mice reduces insulin resistance and improves glucose clearance. These findings highlight the therapeutic potential of lysosome-acidifying TFSA NPs for T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
- College of Biological Sciences, University of Minnesota, Minneapolis, Minnesota 55455, United States.
- Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States.
- Department of Chemistry, Boston University, Boston, Massachusetts 02215, United States.
- Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90045, United States.
- Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, California 90095, United States.
ORCID-Profile: Chih Hung Lo, Kaitlynn M Lopes, Mark W Grinstaff, Jialiu Zeng
Förderung
- Momental Foundation
- Nanyang Technological University
Zitieren
APA
Lo, C. H., O'Connor, L. M., Loi, G. W. Z., Saipuljumri, E. N., Indajang, J., Lopes, K. M., Shirihai, O. S., Grinstaff, M. W., & Zeng, J. (2024). Acidic Nanoparticles Restore Lysosomal Acidification and Rescue Metabolic Dysfunction in Pancreatic β-Cells under Lipotoxic Conditions. ACS Nano, 18(24), 15452-15467. https://doi.org/10.1021/acsnano.3c09206
Vancouver
Lo CH, O'Connor LM, Loi GWZ, Saipuljumri EN, Indajang J, Lopes KM, et al. Acidic Nanoparticles Restore Lysosomal Acidification and Rescue Metabolic Dysfunction in Pancreatic β-Cells under Lipotoxic Conditions. ACS Nano. 2024;18(24):15452-15467. doi:10.1021/acsnano.3c09206
BibTeX
@article{Lo2024,
author = {Lo, Chih Hung and O'Connor, Lance M and Loi, Gavin Wen Zhao and Saipuljumri, Eka Norfaishanty and Indajang, Jonathan and Lopes, Kaitlynn M and Shirihai, Orian S and Grinstaff, Mark W and Zeng, Jialiu},
title = {Acidic Nanoparticles Restore Lysosomal Acidification and Rescue Metabolic Dysfunction in Pancreatic β-Cells under Lipotoxic Conditions},
journal = {ACS Nano},
year = {2024},
volume = {18},
number = {24},
pages = {15452--15467},
doi = {10.1021/acsnano.3c09206}
}
EUVIMED